Global Oral Antidiabetic Agents Market Growth (Status and Outlook) 2025-2031

September 2025 | 81 pages | ID: G1E14E36D39EN
LP Information

Abstracts

According to this study, the global Oral Antidiabetic Agents market size will reach US$ million by 2031.

Oral Antidiabetic Agents refer to the oral drugs used to treat type 2 diabetes in patients who uncontrolled by diet and exercise. Currently, there are five distinct classes of hypoglycemic agents available include sulfonylureas, meglitinides, biguanides, thiazolidinediones and alpha-glucosidase inhibitors.

United States market for Oral Antidiabetic Agents is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Oral Antidiabetic Agents is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Oral Antidiabetic Agents is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Oral Antidiabetic Agents players cover Novo Nordisk, Eli Lilly, Sanofi, Roche, Teva, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Oral Antidiabetic Agents Industry Forecast” looks at past sales and reviews total world Oral Antidiabetic Agents sales in 2024, providing a comprehensive analysis by region and market sector of projected Oral Antidiabetic Agents sales for 2025 through 2031. With Oral Antidiabetic Agents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Antidiabetic Agents industry.

This Insight Report provides a comprehensive analysis of the global Oral Antidiabetic Agents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oral Antidiabetic Agents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral Antidiabetic Agents market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Antidiabetic Agents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Antidiabetic Agents.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Antidiabetic Agents market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Sulfonylureas
• Meglitinides
• Biguanides
• Thiazolidinediones
• Alpha-glucosidase Inhibitors

Segmentation by Application:

• Home Use
• Medical Institutions
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Novo Nordisk
• Eli Lilly
• Sanofi
• Roche
• Teva
• AstraZeneca
• Wockhardt UK
• Merck
• Pfizer
• Cipla

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Oral Antidiabetic Agents Market Size (2020-2031)
  2.1.2 Oral Antidiabetic Agents Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Oral Antidiabetic Agents by Country/Region (2020, 2024 & 2031)
2.2 Oral Antidiabetic Agents Segment by Type
  2.2.1 Sulfonylureas
  2.2.2 Meglitinides
  2.2.3 Biguanides
  2.2.4 Thiazolidinediones
  2.2.5 Alpha-glucosidase Inhibitors
2.3 Oral Antidiabetic Agents Market Size by Type
  2.3.1 Oral Antidiabetic Agents Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Oral Antidiabetic Agents Market Size Market Share by Type (2020-2025)
2.4 Oral Antidiabetic Agents Segment by Application
  2.4.1 Home Use
  2.4.2 Medical Institutions
  2.4.3 Others
2.5 Oral Antidiabetic Agents Market Size by Application
  2.5.1 Oral Antidiabetic Agents Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Oral Antidiabetic Agents Market Size Market Share by Application (2020-2025)

3 ORAL ANTIDIABETIC AGENTS MARKET SIZE BY PLAYER

3.1 Oral Antidiabetic Agents Market Size Market Share by Player
  3.1.1 Global Oral Antidiabetic Agents Revenue by Player (2020-2025)
  3.1.2 Global Oral Antidiabetic Agents Revenue Market Share by Player (2020-2025)
3.2 Global Oral Antidiabetic Agents Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ORAL ANTIDIABETIC AGENTS BY REGION

4.1 Oral Antidiabetic Agents Market Size by Region (2020-2025)
4.2 Global Oral Antidiabetic Agents Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oral Antidiabetic Agents Market Size Growth (2020-2025)
4.4 APAC Oral Antidiabetic Agents Market Size Growth (2020-2025)
4.5 Europe Oral Antidiabetic Agents Market Size Growth (2020-2025)
4.6 Middle East & Africa Oral Antidiabetic Agents Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Oral Antidiabetic Agents Market Size by Country (2020-2025)
5.2 Americas Oral Antidiabetic Agents Market Size by Type (2020-2025)
5.3 Americas Oral Antidiabetic Agents Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Oral Antidiabetic Agents Market Size by Region (2020-2025)
6.2 APAC Oral Antidiabetic Agents Market Size by Type (2020-2025)
6.3 APAC Oral Antidiabetic Agents Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Oral Antidiabetic Agents Market Size by Country (2020-2025)
7.2 Europe Oral Antidiabetic Agents Market Size by Type (2020-2025)
7.3 Europe Oral Antidiabetic Agents Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Oral Antidiabetic Agents by Region (2020-2025)
8.2 Middle East & Africa Oral Antidiabetic Agents Market Size by Type (2020-2025)
8.3 Middle East & Africa Oral Antidiabetic Agents Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ORAL ANTIDIABETIC AGENTS MARKET FORECAST

10.1 Global Oral Antidiabetic Agents Forecast by Region (2026-2031)
  10.1.1 Global Oral Antidiabetic Agents Forecast by Region (2026-2031)
  10.1.2 Americas Oral Antidiabetic Agents Forecast
  10.1.3 APAC Oral Antidiabetic Agents Forecast
  10.1.4 Europe Oral Antidiabetic Agents Forecast
  10.1.5 Middle East & Africa Oral Antidiabetic Agents Forecast
10.2 Americas Oral Antidiabetic Agents Forecast by Country (2026-2031)
  10.2.1 United States Market Oral Antidiabetic Agents Forecast
  10.2.2 Canada Market Oral Antidiabetic Agents Forecast
  10.2.3 Mexico Market Oral Antidiabetic Agents Forecast
  10.2.4 Brazil Market Oral Antidiabetic Agents Forecast
10.3 APAC Oral Antidiabetic Agents Forecast by Region (2026-2031)
  10.3.1 China Oral Antidiabetic Agents Market Forecast
  10.3.2 Japan Market Oral Antidiabetic Agents Forecast
  10.3.3 Korea Market Oral Antidiabetic Agents Forecast
  10.3.4 Southeast Asia Market Oral Antidiabetic Agents Forecast
  10.3.5 India Market Oral Antidiabetic Agents Forecast
  10.3.6 Australia Market Oral Antidiabetic Agents Forecast
10.4 Europe Oral Antidiabetic Agents Forecast by Country (2026-2031)
  10.4.1 Germany Market Oral Antidiabetic Agents Forecast
  10.4.2 France Market Oral Antidiabetic Agents Forecast
  10.4.3 UK Market Oral Antidiabetic Agents Forecast
  10.4.4 Italy Market Oral Antidiabetic Agents Forecast
  10.4.5 Russia Market Oral Antidiabetic Agents Forecast
10.5 Middle East & Africa Oral Antidiabetic Agents Forecast by Region (2026-2031)
  10.5.1 Egypt Market Oral Antidiabetic Agents Forecast
  10.5.2 South Africa Market Oral Antidiabetic Agents Forecast
  10.5.3 Israel Market Oral Antidiabetic Agents Forecast
  10.5.4 Turkey Market Oral Antidiabetic Agents Forecast
10.6 Global Oral Antidiabetic Agents Forecast by Type (2026-2031)
10.7 Global Oral Antidiabetic Agents Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Oral Antidiabetic Agents Forecast

11 KEY PLAYERS ANALYSIS

11.1 Novo Nordisk
  11.1.1 Novo Nordisk Company Information
  11.1.2 Novo Nordisk Oral Antidiabetic Agents Product Offered
  11.1.3 Novo Nordisk Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Novo Nordisk Main Business Overview
  11.1.5 Novo Nordisk Latest Developments
11.2 Eli Lilly
  11.2.1 Eli Lilly Company Information
  11.2.2 Eli Lilly Oral Antidiabetic Agents Product Offered
  11.2.3 Eli Lilly Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Eli Lilly Main Business Overview
  11.2.5 Eli Lilly Latest Developments
11.3 Sanofi
  11.3.1 Sanofi Company Information
  11.3.2 Sanofi Oral Antidiabetic Agents Product Offered
  11.3.3 Sanofi Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Sanofi Main Business Overview
  11.3.5 Sanofi Latest Developments
11.4 Roche
  11.4.1 Roche Company Information
  11.4.2 Roche Oral Antidiabetic Agents Product Offered
  11.4.3 Roche Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Roche Main Business Overview
  11.4.5 Roche Latest Developments
11.5 Teva
  11.5.1 Teva Company Information
  11.5.2 Teva Oral Antidiabetic Agents Product Offered
  11.5.3 Teva Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Teva Main Business Overview
  11.5.5 Teva Latest Developments
11.6 AstraZeneca
  11.6.1 AstraZeneca Company Information
  11.6.2 AstraZeneca Oral Antidiabetic Agents Product Offered
  11.6.3 AstraZeneca Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 AstraZeneca Main Business Overview
  11.6.5 AstraZeneca Latest Developments
11.7 Wockhardt UK
  11.7.1 Wockhardt UK Company Information
  11.7.2 Wockhardt UK Oral Antidiabetic Agents Product Offered
  11.7.3 Wockhardt UK Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Wockhardt UK Main Business Overview
  11.7.5 Wockhardt UK Latest Developments
11.8 Merck
  11.8.1 Merck Company Information
  11.8.2 Merck Oral Antidiabetic Agents Product Offered
  11.8.3 Merck Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Merck Main Business Overview
  11.8.5 Merck Latest Developments
11.9 Pfizer
  11.9.1 Pfizer Company Information
  11.9.2 Pfizer Oral Antidiabetic Agents Product Offered
  11.9.3 Pfizer Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Pfizer Main Business Overview
  11.9.5 Pfizer Latest Developments
11.10 Cipla
  11.10.1 Cipla Company Information
  11.10.2 Cipla Oral Antidiabetic Agents Product Offered
  11.10.3 Cipla Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Cipla Main Business Overview
  11.10.5 Cipla Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Oral Antidiabetic Agents Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Oral Antidiabetic Agents Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Sulfonylureas
Table 4. Major Players of Meglitinides
Table 5. Major Players of Biguanides
Table 6. Major Players of Thiazolidinediones
Table 7. Major Players of Alpha-glucosidase Inhibitors
Table 8. Oral Antidiabetic Agents Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Oral Antidiabetic Agents Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Oral Antidiabetic Agents Market Size Market Share by Type (2020-2025)
Table 11. Oral Antidiabetic Agents Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Oral Antidiabetic Agents Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Oral Antidiabetic Agents Market Size Market Share by Application (2020-2025)
Table 14. Global Oral Antidiabetic Agents Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Oral Antidiabetic Agents Revenue Market Share by Player (2020-2025)
Table 16. Oral Antidiabetic Agents Key Players Head office and Products Offered
Table 17. Oral Antidiabetic Agents Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Oral Antidiabetic Agents Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Oral Antidiabetic Agents Market Size Market Share by Region (2020-2025)
Table 22. Global Oral Antidiabetic Agents Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Oral Antidiabetic Agents Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Oral Antidiabetic Agents Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Oral Antidiabetic Agents Market Size Market Share by Country (2020-2025)
Table 26. Americas Oral Antidiabetic Agents Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Oral Antidiabetic Agents Market Size Market Share by Type (2020-2025)
Table 28. Americas Oral Antidiabetic Agents Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Oral Antidiabetic Agents Market Size Market Share by Application (2020-2025)
Table 30. APAC Oral Antidiabetic Agents Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Oral Antidiabetic Agents Market Size Market Share by Region (2020-2025)
Table 32. APAC Oral Antidiabetic Agents Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Oral Antidiabetic Agents Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Oral Antidiabetic Agents Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Oral Antidiabetic Agents Market Size Market Share by Country (2020-2025)
Table 36. Europe Oral Antidiabetic Agents Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Oral Antidiabetic Agents Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Oral Antidiabetic Agents Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Oral Antidiabetic Agents Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Oral Antidiabetic Agents Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Oral Antidiabetic Agents
Table 42. Key Market Challenges & Risks of Oral Antidiabetic Agents
Table 43. Key Industry Trends of Oral Antidiabetic Agents
Table 44. Global Oral Antidiabetic Agents Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Oral Antidiabetic Agents Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Oral Antidiabetic Agents Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Oral Antidiabetic Agents Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. Novo Nordisk Details, Company Type, Oral Antidiabetic Agents Area Served and Its Competitors
Table 49. Novo Nordisk Oral Antidiabetic Agents Product Offered
Table 50. Novo Nordisk Oral Antidiabetic Agents Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Novo Nordisk Main Business
Table 52. Novo Nordisk Latest Developments
Table 53. Eli Lilly Details, Company Type, Oral Antidiabetic Agents Area Served and Its Competitors
Table 54. Eli Lilly Oral Antidiabetic Agents Product Offered
Table 55. Eli Lilly Oral Antidiabetic Agents Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Eli Lilly Main Business
Table 57. Eli Lilly Latest Developments
Table 58. Sanofi Details, Company Type, Oral Antidiabetic Agents Area Served and Its Competitors
Table 59. Sanofi Oral Antidiabetic Agents Product Offered
Table 60. Sanofi Oral Antidiabetic Agents Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Sanofi Main Business
Table 62. Sanofi Latest Developments
Table 63. Roche Details, Company Type, Oral Antidiabetic Agents Area Served and Its Competitors
Table 64. Roche Oral Antidiabetic Agents Product Offered
Table 65. Roche Oral Antidiabetic Agents Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Roche Main Business
Table 67. Roche Latest Developments
Table 68. Teva Details, Company Type, Oral Antidiabetic Agents Area Served and Its Competitors
Table 69. Teva Oral Antidiabetic Agents Product Offered
Table 70. Teva Oral Antidiabetic Agents Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Teva Main Business
Table 72. Teva Latest Developments
Table 73. AstraZeneca Details, Company Type, Oral Antidiabetic Agents Area Served and Its Competitors
Table 74. AstraZeneca Oral Antidiabetic Agents Product Offered
Table 75. AstraZeneca Oral Antidiabetic Agents Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. AstraZeneca Main Business
Table 77. AstraZeneca Latest Developments
Table 78. Wockhardt UK Details, Company Type, Oral Antidiabetic Agents Area Served and Its Competitors
Table 79. Wockhardt UK Oral Antidiabetic Agents Product Offered
Table 80. Wockhardt UK Oral Antidiabetic Agents Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. Wockhardt UK Main Business
Table 82. Wockhardt UK Latest Developments
Table 83. Merck Details, Company Type, Oral Antidiabetic Agents Area Served and Its Competitors
Table 84. Merck Oral Antidiabetic Agents Product Offered
Table 85. Merck Oral Antidiabetic Agents Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. Merck Main Business
Table 87. Merck Latest Developments
Table 88. Pfizer Details, Company Type, Oral Antidiabetic Agents Area Served and Its Competitors
Table 89. Pfizer Oral Antidiabetic Agents Product Offered
Table 90. Pfizer Oral Antidiabetic Agents Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Pfizer Main Business
Table 92. Pfizer Latest Developments
Table 93. Cipla Details, Company Type, Oral Antidiabetic Agents Area Served and Its Competitors
Table 94. Cipla Oral Antidiabetic Agents Product Offered
Table 95. Cipla Oral Antidiabetic Agents Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. Cipla Main Business
Table 97. Cipla Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Oral Antidiabetic Agents Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oral Antidiabetic Agents Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Oral Antidiabetic Agents Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Oral Antidiabetic Agents Sales Market Share by Country/Region (2024)
Figure 8. Oral Antidiabetic Agents Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Oral Antidiabetic Agents Market Size Market Share by Type in 2024
Figure 10. Oral Antidiabetic Agents in Home Use
Figure 11. Global Oral Antidiabetic Agents Market: Home Use (2020-2025) & ($ millions)
Figure 12. Oral Antidiabetic Agents in Medical Institutions
Figure 13. Global Oral Antidiabetic Agents Market: Medical Institutions (2020-2025) & ($ millions)
Figure 14. Oral Antidiabetic Agents in Others
Figure 15. Global Oral Antidiabetic Agents Market: Others (2020-2025) & ($ millions)
Figure 16. Global Oral Antidiabetic Agents Market Size Market Share by Application in 2024
Figure 17. Global Oral Antidiabetic Agents Revenue Market Share by Player in 2024
Figure 18. Global Oral Antidiabetic Agents Market Size Market Share by Region (2020-2025)
Figure 19. Americas Oral Antidiabetic Agents Market Size 2020-2025 ($ millions)
Figure 20. APAC Oral Antidiabetic Agents Market Size 2020-2025 ($ millions)
Figure 21. Europe Oral Antidiabetic Agents Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Oral Antidiabetic Agents Market Size 2020-2025 ($ millions)
Figure 23. Americas Oral Antidiabetic Agents Value Market Share by Country in 2024
Figure 24. United States Oral Antidiabetic Agents Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Oral Antidiabetic Agents Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Oral Antidiabetic Agents Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Oral Antidiabetic Agents Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Oral Antidiabetic Agents Market Size Market Share by Region in 2024
Figure 29. APAC Oral Antidiabetic Agents Market Size Market Share by Type (2020-2025)
Figure 30. APAC Oral Antidiabetic Agents Market Size Market Share by Application (2020-2025)
Figure 31. China Oral Antidiabetic Agents Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Oral Antidiabetic Agents Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Oral Antidiabetic Agents Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Oral Antidiabetic Agents Market Size Growth 2020-2025 ($ millions)
Figure 35. India Oral Antidiabetic Agents Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Oral Antidiabetic Agents Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Oral Antidiabetic Agents Market Size Market Share by Country in 2024
Figure 38. Europe Oral Antidiabetic Agents Market Size Market Share by Type (2020-2025)
Figure 39. Europe Oral Antidiabetic Agents Market Size Market Share by Application (2020-2025)
Figure 40. Germany Oral Antidiabetic Agents Market Size Growth 2020-2025 ($ millions)
Figure 41. France Oral Antidiabetic Agents Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Oral Antidiabetic Agents Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Oral Antidiabetic Agents Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Oral Antidiabetic Agents Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Oral Antidiabetic Agents Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Oral Antidiabetic Agents Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Oral Antidiabetic Agents Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Oral Antidiabetic Agents Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Oral Antidiabetic Agents Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Oral Antidiabetic Agents Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Oral Antidiabetic Agents Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Oral Antidiabetic Agents Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Oral Antidiabetic Agents Market Size 2026-2031 ($ millions)
Figure 54. APAC Oral Antidiabetic Agents Market Size 2026-2031 ($ millions)
Figure 55. Europe Oral Antidiabetic Agents Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Oral Antidiabetic Agents Market Size 2026-2031 ($ millions)
Figure 57. United States Oral Antidiabetic Agents Market Size 2026-2031 ($ millions)
Figure 58. Canada Oral Antidiabetic Agents Market Size 2026-2031 ($ millions)
Figure 59. Mexico Oral Antidiabetic Agents Market Size 2026-2031 ($ millions)
Figure 60. Brazil Oral Antidiabetic Agents Market Size 2026-2031 ($ millions)
Figure 61. China Oral Antidiabetic Agents Market Size 2026-2031 ($ millions)
Figure 62. Japan Oral Antidiabetic Agents Market Size 2026-2031 ($ millions)
Figure 63. Korea Oral Antidiabetic Agents Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Oral Antidiabetic Agents Market Size 2026-2031 ($ millions)
Figure 65. India Oral Antidiabetic Agents Market Size 2026-2031 ($ millions)
Figure 66. Australia Oral Antidiabetic Agents Market Size 2026-2031 ($ millions)
Figure 67. Germany Oral Antidiabetic Agents Market Size 2026-2031 ($ millions)
Figure 68. France Oral Antidiabetic Agents Market Size 2026-2031 ($ millions)
Figure 69. UK Oral Antidiabetic Agents Market Size 2026-2031 ($ millions)
Figure 70. Italy Oral Antidiabetic Agents Market Size 2026-2031 ($ millions)
Figure 71. Russia Oral Antidiabetic Agents Market Size 2026-2031 ($ millions)
Figure 72. Egypt Oral Antidiabetic Agents Market Size 2026-2031 ($ millions)
Figure 73. South Africa Oral Antidiabetic Agents Market Size 2026-2031 ($ millions)
Figure 74. Israel Oral Antidiabetic Agents Market Size 2026-2031 ($ millions)
Figure 75. Turkey Oral Antidiabetic Agents Market Size 2026-2031 ($ millions)
Figure 76. Global Oral Antidiabetic Agents Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Oral Antidiabetic Agents Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Oral Antidiabetic Agents Market Size 2026-2031 ($ millions)